Cancer treatment has evolved dramatically with the development of targeted therapies and immunotherapy. Targeted therapies specifically attack cancer cells by focusing on molecular targets associated with cancer, leading to more effective and less toxic treatments. Immunotherapy, such as checkpoint inhibitors and CAR-T cell therapy, has revolutionized cancer care by harnessing the body's immune system to fight the disease. These therapies have shown remarkable success in treating cancers like melanoma and certain types of leukemia.
